Agenda

CME accreditation badge

This program has been accredited for 1 hour of CME credit.

Learning objectives 

Following the symposium, learners will be able to:  

  • Identify the limitations of current approved therapies and remaining unmet clinical needs in the treatment of myelofibrosis. 
  • Explain the biological mechanisms underlying myelofibrosis and the rationale for multi-pathway targeting.  
  • Evaluate the efficacy, safety, and potential clinical roles of current and emerging JAKi-based combination approaches for patients with myelofibrosis.  
  • Assess emerging evidence and clinical considerations that may inform the future optimization of combination treatment strategies in myelofibrosis.   

Registration form

Registration is free.

By registering for this symposium, you confirm that you are not an HCP practicing in the UK or USA. This content is intended solely for HCPs practicing outside these jurisdictions.

Required fields

Thank you!

You have successfully registered for the webinar.

Please check your email for further information on how to attend.

Add to Calendar